As the opioid crisis continues to impact communities across the world, a physician-scientist at USA Health has been named the principal investigator of an international phase II clinical trial to evaluate the safety of a drug for babies born with neonatal opioid withdrawal syndrome.
At the Mitchell Cancer Institute (MCI), we focus on saving lives. Our physicians, scientists and students collaborate to provide innovative patient therapy and research, along with educating the next generation of caregivers.
Members of the MCI faculty educate USA undergraduates, medical students, residents, allied health students and other graduate students. Many MCI faculty members hold dual appointments with departments and colleges within USA Health.
Residents participate in clinical rotations with MCI medical oncology faculty, and allied health students participate in educational rotations at the center. Graduate students also work with scientists in our research program.
Community Health and Support at Mitchell Cancer Institute
Navigating a cancer diagnosis and the many steps that follow is not a simple process. At Mitchell Cancer Institute, our support staff and programs assist patients during their individual journeys through this difficult time.
Based on the needs and stage of the patients, USA Health offers two types of patient navigators.
Oncologynurse navigators are their first resource in handling clinical needs, such as coordination, education, discussing treatment plans, forming survivor plans and much more. Nurse navigators also assist patients with referrals to other specialists, surgeons or dietitians.
Lay navigators assist with such non-clinical as transportation, financial issues, social and community services, and other personal matters that may arise. These navigators are not trained nurses but serve as a valuable resource to help patients during their treatment and recovery.